share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Shanahan Karin

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施贵宝 | 4：持股变动声明
SEC announcement ·  03/12 17:54
Moomoo AI 已提取核心信息
Bristol-Myers Squibb EVP, Karin Shanahan, completed a transaction involving the company's common stock on March 10, 2024. The action involved direct and indirect holdings, with Shanahan now owning a total of 3,226 shares directly and 818.59 shares indirectly through the BMS Savings and Investment Program. The common stock is listed with a par value of $0.10. This transaction reflects changes in the executive's stake in the company, which is a key interest for investors monitoring insider activity.
Bristol-Myers Squibb EVP, Karin Shanahan, completed a transaction involving the company's common stock on March 10, 2024. The action involved direct and indirect holdings, with Shanahan now owning a total of 3,226 shares directly and 818.59 shares indirectly through the BMS Savings and Investment Program. The common stock is listed with a par value of $0.10. This transaction reflects changes in the executive's stake in the company, which is a key interest for investors monitoring insider activity.
百时美施贵宝执行副总裁卡琳·沙纳汉于2024年3月10日完成了一项涉及该公司普通股的交易。该行动涉及直接和间接持有，沙纳汉现在直接持有总计3,226股股票，通过BMS储蓄和投资计划间接拥有818.59股股票。普通股的面值为0.10美元。该交易反映了该公司高管股份的变化，这是监督内部活动的投资者的主要利益。
百时美施贵宝执行副总裁卡琳·沙纳汉于2024年3月10日完成了一项涉及该公司普通股的交易。该行动涉及直接和间接持有，沙纳汉现在直接持有总计3,226股股票，通过BMS储蓄和投资计划间接拥有818.59股股票。普通股的面值为0.10美元。该交易反映了该公司高管股份的变化，这是监督内部活动的投资者的主要利益。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息